AVCRF — Avricore Health Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1355736 ·
Last close
$0.00
Market Cap
$101.1K
52W High
$0.08
52W Low
$0.00
ADV30
736
Next earnings
2026-08-31
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 77,595 | 1,472 | -238,359 | -275,352 | 1,238,774 | 912,548 | 129,172 |
| Mar 2026 | 44,315 | -8,580 | -240,042 | -204,893 | 584,369 | 200,301 | 389,166 |
| Dec 2025 | 33,451 | -7,307 | -341,979 | -943,089 | 563,125 | 227,918 | 173,561 |
| Sep 2025 | 37,680 | -52,600 | -379,084 | -379,288 | 1,329,290 | 531,752 | 35,885 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,034,812
Investing CF
$-34,835
Financing CF
$0
CapEx
$-34,835
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-34,468,177
Inventory
$39,478
Receivables
$53,721
ST Investments
$10,000
EBIT TTM
$-1,432,668
Pretax Income TTM
$-1,986,278
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$193,041
EBITDA
$-1,101,769
Free Cash Flow
$-556,631
Enterprise Value
$-821,325
Total Cash
$922,548
Total Debt
$0
Shares Out
126,369,664
Trailing EPS
$-0.01
Book Value
$0.00
ROE
-132.0%
ROA
-50.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 533,884 | -1,266,436 | -1,858,747 | 563,125 | 173,561 | 389,564 | -789,933 |
| Dec 2024 | 4,785,711 | 139,348 | -668,977 | 2,298,544 | 330,817 | 1,967,727 | 1,004,615 |
| Dec 2023 | 3,485,147 | -687,245 | -701,215 | 2,538,205 | 529,218 | 2,008,987 | 660,403 |
| Dec 2022 | 1,768,374 | -812,524 | -818,228 | 2,568,983 | 604,893 | 1,964,090 | -437,832 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| OWPC | One World Products, Inc. | $96.1K | $0.00 | — |
| PKTX | ProtoKinetix, Inc. | $82.3K | $0.00 | — |
| PRPH | ProPhase Labs, Inc. | $155.9K | $0.01 | — |
| CNBX | CNBX Pharmaceuticals Inc. | $160.6K | $0.00 | — |
| RGBP | Regen BioPharma Inc | $167.5K | $0.00 | — |
News headlines (Yahoo Finance, 1h cache)
HealthTab™ Programme Expands Nationally Across England
2026-09-01 10:30 · Yahoo
Avricore Grants Options
2026-08-28 10:30 · Yahoo
HealthTab™ Enters Multi-Year Collaboration Agreement with Abbott for Point-of-Care Testing Across the UK
2026-08-20 10:30 · Yahoo
Avricore Health Closes $1.254 Million Financing
2026-06-17 10:30 · Yahoo
Avricore Health Announces $1.25 Million Financing
2026-05-20 10:55 · Yahoo
Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform
2026-04-21 10:30 · Yahoo
Sector Update: Healthcare Stocks Fall Thursday Afternoon
2026-08-20 17:43 · Yahoo
Avricore Health Outlines UK Expansion Roadmap for HealthTab Platform
2026-04-21 12:45 · Yahoo
HealthTab™ to Power NHS Pilot
2025-11-27 22:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.